Solventum Corporation develops, manufactures, and commercializes medical devices and healthcare software across three primary segments. The Medsurg segment supplies advanced wound management solutions, including negative pressure wound therapy and specialized dressings, alongside surgical supplies, temperature management devices, sterilization assurance products, and medical consumables such as electrodes and tapes. The company also serves original equipment manufacturers with medical technologies. The Dental Solutions segment offers orthodontic and restorative products, including brackets, aligners, cements, and bonding agents. The Health Information Systems segment provides software platforms and services for healthcare organizations, encompassing physician documentation automation, coding and billing solutions, and data analytics tools.
The company operates through multiple distribution channels including direct-to-consumer, wholesale distribution, key account management, and e-commerce. Solventum maintains a geographic presence across the United States and international markets. The company was incorporated in Delaware in 2023 and is headquartered in Maplewood, Minnesota. As a medical device and healthcare IT company, Solventum competes in the surgical instruments, supplies, dental products, and healthcare software segments of the broader medical technology industry.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $8.88 | $8.94 | +221.7% | |
| 2024 | $2.76 | $2.77 | — |